Author

Hee Won Yang

Columbia University Irving Medical CenterORCID 0000-0002-0000-8091Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Eugene Son· 1 shared Jessica ArmandiD· 1 shared Kevin M. KalinskyiD· 1 shared Kibum Kim· 1 shared Minah KimiD· 1 shared Sungsoo KimiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eugene Son

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyeLifePeer-reviewedDec 29, 2025

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

Jessica Armand, Sungsoo Kim, Kibum Kim…·Hee Won Yang

This study shows that continuing CDK4/6 inhibitors and adding CDK2 inhibitors slows growth of drug-resistant breast cancer by delaying cell cycle progression and reducing E2F transcription.

7 citations

humanproteomics

𝕏 PostBluesky